Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Incidentie hepatitis C daalt na beschikbaar komen DAA’s
apr 2018 | Hepatitis